AqVida Development, Registration and Supply of Generic Oncology Products and Biosimilars

AqVida is a pharmaceutical company that focuses on the development, registration and supply of generic oncology products and biosimilars.

Many of our finished products, such as Paclitaxel, Docetaxel or Oxaliplatin, have a considerable market share in Germany, and we are also involved in new development projects in the oncology sector.

Our products are offered under our own AqVida brand, or under our partners’ brands in the EU and less regulated markets. AqVida also offers active pharmaceutical ingredients (API) with all the necessary documentation, as well as full supply chain qualification.

Pharmaceutical services ranging from API sourcing to EU market release

As a pharmaceutical company, AqVida offers all the necessary competencies, from API sourcing to EU market release for finished products. Our direct line, internal as well as external, gives us the opportunity to react and move quickly. AqVida’s experts in development, regulatory affairs, patent issues and laboratory work closely together to get the best results for our clients.

We have extensive knowledge of international market and registration conditions. Depending on the client’s requirements, we can accompany them from development to successful launch.

Development and registration of oncology products

Since the beginning, AqVida has been involved in the development of highly complex and highly ethical products, mainly in the field of anti-cancer medicines. After launching our biosimilar filgrastim to the market, we have focused on other biosimilar products to follow, as well as molecular-targeted anti-cancer molecules (tinibs).

Our regulatory affairs team accompanies the development from the start and also manages our procedures in Europe, to match the required national, European or international standards.

GMP-certified processes

AqVida’s quality management system conforms to all German and EU legal requirements for the pharmaceutical industry, including AMG, AMWHV and EU-GMP, and is GMP certified by the German Health Authorities.

Our in-house laboratory provides the entire infrastructure, so that our qualified team can conduct analytics and quality control according to our strict quality management processes. The AqVida laboratory conducts batch analysis, as well as releases to markets according to all respective European standards.

Partner for the pharmaceutical industry

We tailor our business models according to our clients’ needs and can provide API supply, dossiers for registration and development purposes, technology transfers – depending on manufacturing facilities and market conditions -, as well as registered and released products for the European market.

We also develop portfolio, marketing and sales strategies together with our clients.

EU registration, certification and support for pharmaceutical manufacturers

We offer pharmaceutical manufacturers entry into the European market. Together we work on optimising processes and quality standards to match the required criteria.

Additionally, we run registration procedures and can multiply your registration in several EU countries, enabling you to cover several channels with one registration procedure. Once the registration is obtained we are able to offer EU release for imported products.

We have supported several manufacturers in receiving a German GMP certification by carrying out audits and inspections with the German Health Authorities.

Make an enquiry

Follow this company

Follow the company to be always up to date with this company

Press Release

AqVida is Exhibitor on the CPHI

AqVida is a German pharmaceutical company specialised in the development, registration and distribution of finished dosage forms mainly in the oncology sector.

White Papers

AqVida Active Pharmaceutical Ingredients List

AqVida is involved in the the development, registration and supply of generic oncology products and biosimilars, and also supplies active pharmaceutical ingredients (API) with all the necessary documentation and full supply chain qualification.

Address
AqVida GmbH

Kaiser-Wilhelm-Straße 89

D-20355 Hamburg

Other

Germany

+49 40 380 371 90 +49 40 380 371 92 www.aqvida.com

AqVida Images

Products and Services

Video

Press Release

19 September 2013

AqVida is a German pharmaceutical company specialised in the development, registration and distribution of finished dosage forms mainly in the oncology sector.

Read more
16 October 2012

As from October onwards, AqVida, located in Hamburg, will be also present in the south of Germany. With the new office in Bavaria, AqVida further optimises its production chain.

Read more
19 April 2009

Despite fierce competition on generic Oxaliplatin, AqVida is convinced it can generate major sales of the product due to the low level of production costs and transfer prices. The product will be available for out-licensing in August. AqVida has confirmed talks with several interested

Read more

Regional Offices

AqVida GmbH

Kaiser-Wilhelm-Straße 89

D-20355 Hamburg

Other

Germany

+49 40 380 371 90 +49 40 380 371 92 www.aqvida.com
AqVida GmbH Office China

Room 18, No. 11 Qinchun Road

Kaises Commercial Center

31009 Hangzhou

Other

China

+86 57187 228980 +86 57187 228987 www.aqvida.com

Contact company

I have read and accept the terms and conditions and privacy policy.
We'd like to keep you informed about relevant promotions, products and services, if you would like not to receive these, check this box.
If you would like to hear from carefully selected third party companies, check this box
Follow this company to receive notifications when they update.